Blackstone Inc. (NYSE:BX) is acquiring Apartment Income REIT in a deal expected to be completed soon, pending final closing conditions.
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 2/25/2026 | $43.00 | Outperform → Market Perform | BMO Capital Markets | |
| 2/24/2026 | $179.00 | Outperform | RBC Capital Mkts | |
| 12/11/2025 | $175.00 | Neutral | UBS | |
| 12/1/2025 | $64.00 | Hold | Jefferies | |
| 11/20/2025 | $60.00 | Neutral | Piper Sandler | |
| 10/3/2025 | $190.00 | Outperform | BMO Capital Markets | |
| 9/17/2025 | $60.00 | Equal Weight → Overweight | Wells Fargo | |
| 9/16/2025 | $64.00 | Outperform | Wolfe Research |
4 - Blackstone Inc. (0001393818) (Reporting)
4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)
4 - Blackstone Inc. (0001393818) (Issuer)
Expected to Generate Enough Electricity to Power 500,000 Homes in Louisiana, Project Construction Created Over 400 Local Construction Jobs Blackstone (NYSE:BX) announced today that private equity funds managed by Blackstone Energy Transition Partners ("Blackstone") have completed construction of the Magnolia Power Generating Station ("Magnolia Power"), a 694-megawatt greenfield combined cycle gas turbine ("CCGT") power plant in Plaquemine, Louisiana. Today's announcement marks the beginning of commercial operations at the plant. Blackstone, through its North American power platform, Kindle Energy, started developing Magnolia Power in 2021, at a time when the digitization of data and AI
Blackstone Life Sciences ("BXLS") today announced a research and development funding agreement to advance the clinical development of bleximenib (JNJ-75276617), an investigational oral menin inhibitor, for acute myeloid leukemia ("AML"). AML is the most common type of acute leukemia in adults, yet continues to be extremely challenging to treat, with the lowest survival of all leukemia types. Johnson & Johnson and funds managed by BXLS will jointly finance a portion of the ongoing and future clinical trials of bleximenib in AML. This is the first time that BXLS and Johnson & Johnson have entered into a co-funding agreement. "We believe that bleximenib's promising clinical data, combined
Blackstone (NYSE:BX) announced today that funds managed by Blackstone's perpetual private equity strategy (BXPE) ("Blackstone") have entered into a definitive agreement to acquire Champions Group, a premier provider of essential home services, from Odyssey Investment Partners, LLC ("Odyssey"). Odyssey and management are retaining a significant minority investment alongside Blackstone. Champions Group is a leading residential services platform providing essential home services to the residential repair and replacement market. The Company operates a scaled, integrated model across tier one MSAs with over 1,800 field technicians and 150,000 active members. Champions Group has built a differe
4 - Blackstone Inc. (0001393818) (Reporting)
4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)
4 - Blackstone Inc. (0001393818) (Issuer)
BMO Capital Markets downgraded Ryan Specialty Group from Outperform to Market Perform and set a new price target of $43.00
RBC Capital Mkts initiated coverage of Blackstone with a rating of Outperform and set a new price target of $179.00
UBS resumed coverage of Blackstone with a rating of Neutral and set a new price target of $175.00
S-8 - Blackstone Inc. (0001393818) (Filer)
10-K - Blackstone Inc. (0001393818) (Filer)
13F-HR - Blackstone Inc. (0001393818) (Filer)
Ryan Specialty Completes Canadian Amalgamation Ryan Specialty (NYSE:RYAN), a leading international specialty insurance intermediary, is pleased to announce the appointment of Stephen Stewart, President & CEO of Stewart Specialty Risk Underwriting, a Ryan Specialty managing general underwriter, to the additional role Chief Executive Officer of Ryan Specialty Canada Limited, the newly formed Canadian operating and holding entity for Ryan Specialty's underwriting management businesses in Canada. Ryan Specialty Canada Limited is headquartered in Toronto. With the formation of its Canadian holding entity, Ryan Specialty completes the amalgamation of its Canadian operations, including the Can
Blackstone (NYSE:BX) announced today that Laura Coady, formerly Head of International Securitised Markets and Global Head of CLOs at Jefferies, has joined Blackstone Credit & Insurance ("BXCI") as Global Head of CLOs and European Head of Liquid Credit Strategies (LCS). Based in London, Coady will oversee BXCI's CLO activity globally, including CLO formation and investing, and lead the liquid credit business in Europe. BXCI's LCS business manages $120 billion across corporate bonds, leveraged loans, CLOs and Multi-Asset Credit. Blackstone is the largest global manager of CLOs and loans, and the most active loan trader. The firm set a record for global annual CLO issuance in 2024, beating t
Ryan Specialty Holdings, Inc. (NYSE:RYAN) ("Ryan Specialty" or "the Company"), a leading international specialty insurance firm, today announced that Steve Keogh, Chief Operating Officer, and Brendan Mulshine, Chief Revenue Officer, have been appointed to the additional roles of Co-Presidents of Ryan Specialty. In their roles, Mr. Keogh and Mr. Mulshine will report to Chief Executive Officer, Tim Turner. They succeed Jeremiah Bickham, who has transitioned from his position as President to serve as a strategic advisor through the end of the year. "Steve and Brendan are seasoned insurance executives who have driven strong operational and financial results," said Pat Ryan, Ryan Specialty's F
- Total Revenue grew 13.2% year-over-year to $751.2 million - - Organic Revenue Growth Rate* of 6.6% year-over-year - - Net Income of $31.2 million, or $0.06 per diluted share - - Adjusted EBITDAC* grew 2.9% year-over-year to $222.3 million - - Adjusted Net Income increased 0.5% year-over-year to $124.0 million - - Adjusted Diluted Earnings Per Share was $0.45 per diluted share - - Company Announces $300 million Share Repurchase Authorization - Ryan Specialty Holdings, Inc. (NYSE:RYAN) ("Ryan Specialty" or the "Company"), a leading international specialty insurance firm, today announced results for the fourth quarter ended December 31, 2025. Fourth Quarter 2025 Highlights
Ryan Specialty Holdings, Inc. (NYSE:RYAN) ("Ryan Specialty"), a leading international specialty insurance firm, today announced it will release its Fourth Quarter 2025 financial results after the market closes on Thursday, February 12, 2026. Ryan Specialty will hold a conference call to discuss the financial results at 5:00pm Eastern Time on February 12, 2026. Interested parties may access the conference call through the live webcast, which can be accessed via this link or by visiting the Company's Investor Relations website. Please join the live webcast at least 10 minutes prior to the scheduled start time. A webcast replay of the call will be available at ir.ryanspecialty.com for one
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE:SF), announces the upcoming index rebalancing for the fourth quarter of 2025. This quarter, there are constituent changes within six of our indexes: KBW Nasdaq Insurance Index (Index Ticker: KIX), KBW Nasdaq Regional Banking Index (Index Ticker: KRX, ETF Ticker: KBWR), KBW Nasdaq Financial Sector Dividend Yield Index (Index Ticker: KDX, ETF Ticker: KBWD), KBW Nasdaq Premium Yield Equity REIT Index (Index Ticker: KYX, ETF Ticker: KBWY), KBW Nasdaq Property and Casualty Ins
SC 13G/A - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Subject)
SC 13G - Blackstone Inc. (0001393818) (Subject)
SC 13G - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Subject)